Katsuto Shinohara, MD

Urologic cancer surgeon

Dr. Katsuto Shinohara specializes in urologic cancers, in particular prostate cancer. He has a special interest in innovative biopsy techniques and image-guided minimally invasive treatments for prostate cancer as well as applying ultrasound techniques in the diagnosis, management and treatment of all urologic cancers.

Shinohara earned a medical degree from Yokohama City University, School of Medicine in Yokohama, Japan. Subsequently, he completed a residency in general surgery at Mitsui Memorial Hospital in Tokyo, Japan and a residency in urology at Kitasato University Hospital in Sagamihara, Japan. He then completed a fellowship in urological oncology at the Baylor College of Medicine in Houston, Texas.

Shinohara is a member of numerous professional societies, including the Japanese Urological Association, Japanese Society of Medical Ultrasonics, American Institute of Ultrasound in Medicine, American Urological Association, American Urological Association and Society of Urology and Engineering. He has lectured widely on urologic cancer and his work has been published in numerous medical and scientific journals. He is a professor of urology at UCSF.


Prostate Cancer Center
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Medical Oncology Phone: (415) 476-4616
Surgical Oncology Phone: (415) 353-7171
Medical Oncology Fax: (415) 353-7107
Surgical Oncology Fax: (415) 514-6195

Hours: Monday to Friday
8 a.m. – 5 p.m.

Urologic Surgical Oncology Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 353-7171
New Patient Fax: (415) 514-6195
General Fax: (415) 353-7093

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Academic Title


More about Katsuto Shinohara

Additional Languages



Yokohama City Univ. School of Medicine Japan 1979


Kitasato Univ. Hosp. Japan, Urology 1984


Baylor College of Medicine

Selected Research and Publications

  1. Wu SY, Boreta L, Wu A, Cheung JP, Cunha JAM, Shinohara K, Chang AJ. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy. Brachytherapy. 2018 Mar - Apr; 17(2):259-264.
  2. Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol. 2017 Sep 20.
  3. Kunogi H, Cunha JAM, Chang AJ, Gadzinski AJ, Shinohara K, Hsu IC. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate. Brachytherapy. 2017 Nov - Dec; 16(6):1113-1118.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.